Delayed Prostate Cancer Therapy Copiague NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

YVETTE FRANCIS, MD
(718) 341-1991
23310 Linden Boulevard
Cambria Heights, NY
HAL GERSTEIN, MD
(516) 482-4790
225 Community Drive
Great Neck, NY
Lihong Wei, MD
516-562-4180
300 Community Dr
Manhasset, NY
Pamela Rose Drullinsky, MD
516-256-3651
1000 N Village Ave
Rockville Centre, NY
Jigna Desai Jhaveri, MD
516-222-2020
700 Stewart Ave
Garden City, NY
Steven Allen
(516) 734-8959
450 Lakeville Road
Lake Success, NY
UZMA IQBAL, MD
(718) 470-8939
27005 76Th Avenue
New Hyde Park, NY
ARUNA GUPTA, MD
(516) 364-5400
225 Froehlich Farm Boulevard
Woodbury, NY
Dorothy Chera Pan, MD
516-256-3651
1000 N Village Ave
Rockville Centre, NY
Gerry Helaine Rubin, MD
631-666-0262
180 E Main St
Bay Shore, NY
Data Provided by:
    

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Exercise for Prostate Cancer Copiague NY
Regular exercise may help protect men from prostate cancer, says a new study. U.S. researchers looked at 190 men who had a prostate biopsy and found that those who were moderately active -- anything equivalent to walking at a moderate pace for several hours a week -- were significantly less likely to be diagnosed with prostate cancer.
- Hormone Therapy for Breast Cancer Copiague NY
- Hormone Therapy for Prostate Cancer Copiague NY
- Attack Of The Cancer Fighting Tomatoes Copiague NY
- Open Prostatectomy Versus Laparoscopic Procedure Copiague NY
- Head and Neck Cancer Treatment Copiague NY
- Diagnosis of Prostate Cancer Copiague NY
- Hormone Therapy for Lung Cancer Copiague NY
- Drug Combo Proves Powerful Against Lung Cancer Copiague NY
- Hormone Therapy for Early Prostate Cancer Copiague NY